HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Attenuation of murine acute lethal graft-versus-host disease by the administration of DL-alpha-difluoromethylornithine.

Abstract
Intravenous injection of 5 x 10(7) C57BL/6 (B6) lymphocytes into adult (C57BL/6 x DBA/2)F1 recipient mice results in acute lethal graft-versus-host (ALGVH) disease. This disorder is characterized by anemia, a diminished number of splenocytes, impaired cytotoxicity (CTX) against third party alloantigen, and impaired natural killer cell (NK) activity. Parental anti-F1 CTX is critical to the induction of ALGVH disease, and CTX in general has been reported to be dependent upon the presence of the low molecular weight polyamines essential for cell growth and differentiation. We now report that DL-alpha-difluoromethylornithine, a specific inhibitor of polyamine biosynthesis, attenuates the clinical expression of disease in mice undergoing ALGVH disease.
AuthorsA B Singh, T J Thomas, M Singh, R A Mann
JournalClinical immunology and immunopathology (Clin Immunol Immunopathol) Vol. 65 Issue 3 Pg. 242-6 (Dec 1992) ISSN: 0090-1229 [Print] United States
PMID1451328 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Polyamines
  • Eflornithine
Topics
  • Anemia (etiology)
  • Animals
  • Cytotoxicity, Immunologic (drug effects)
  • Eflornithine (pharmacology)
  • Graft vs Host Disease (drug therapy, immunology)
  • Killer Cells, Natural (immunology)
  • Lymphocyte Activation (drug effects)
  • Male
  • Mice
  • Mice, Inbred Strains
  • Polyamines (metabolism)
  • Spleen (cytology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: